For the year ending 2025-12-31, CMPX has $219,588K in assets. $22,797K in debts. $30,643K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 30,643 | |||
| Marketable securities | 178,263 | |||
| Prepaid expenses and other current assets | 913 | |||
| Total current assets | 209,819 | |||
| Total property and equipmentat cost | 6,739 | |||
| Less accumulated depreciation | 6,637 | |||
| Property and equipment, net | 102 | |||
| Operating lease, right-of-use ('rou') asset | 9,099 | |||
| Restricted cash | 568 | |||
| Total assets | 219,588 | |||
| Accounts payable | 1,585 | |||
| Accrued expenses | 11,383 | |||
| Operating lease obligations, current portion | 1,000 | |||
| Total current liabilities | 13,968 | |||
| Operating lease obligations, long-term portion | 8,829 | |||
| Total liabilities | 22,797 | |||
| Common stock, 0.0001 par value 300,000 shares authorized 178,324 shares issued and outstanding at december 31, 2025 137,820 shares issued and outstanding at december 31, 2024 | 18 | |||
| Additional paid-in-capital | 627,665 | |||
| Accumulated other comprehensive income | 280 | |||
| Accumulated deficit | -431,172 | |||
| Total stockholders' equity | 196,791 | |||
| Total liabilities and stockholders' equity | 219,588 | |||
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)